Home › Funds › Castleview Partners, LLC › GILD

Castleview Partners, LLC position in GILD

GILEAD SCIENCES INC · Health Care

Castleview Partners, LLC reported holding 7,155 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$1.1M, representing 0.47% of its reported portfolio and ranking #49 among its reported holdings. Castleview Partners, LLC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)7.16K sh
Reported value held$1.07M
Portfolio Weight0.47%
First reportedQ3 2023
Last changeAdd
Updated2026-10-10

Last updated: 2026-10-10 · Source: SEC EDGAR Form 13F-HR

How Castleview Partners, LLC's GILD position evolved

Castleview Partners, LLC first disclosed a stake in GILD in Q3 2023 at 1,642 shares (US$123K). The position peaked in Q3 2026 at 7,155 shares, worth US$1.1M. Across 13 filings, Castleview Partners, LLC increased the stake 10 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 7,155 shares valued at US$1.1M — an increase of 869 shares quarter over quarter.. Notable position changes include a 50% increase in Q1 2024 (shares fell 6% over the following quarter), a 37% increase in Q2 2024 (shares rose 22% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.64K $123.05K New
Q4 2023 1.64K $132.78K Hold
Q1 2024 2.46K $180.05K Add
Q2 2024 3.36K $230.32K Add
Q3 2024 3.50K $293.44K Add
Q4 2024 4.17K $383.51K Add
Q1 2025 3.71K $416.15K Reduce
Q2 2025 4.23K $468.65K Add
Q3 2025 4.52K $501.28K Add
Q4 2025 5.01K $614.80K Add
Q1 2026 5.12K $713.71K Add
Q2 2026 6.29K $794.27K Add
Q3 2026 7.16K $1.07M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Castleview Partners, LLC held GILD?

Castleview Partners, LLC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Castleview Partners, LLC's current position in GILD?

As of Q3 2026, Castleview Partners, LLC holds 7.16K shares of GILD (GILEAD SCIENCES INC), valued at $1.07M, representing 0.47% of its reported portfolio and ranking #49.

Has Castleview Partners, LLC been buying or selling GILD?

In the latest 13F filing (Q3 2026), Castleview Partners, LLC increased its position in GILD. The position peaked in Q3 2026 at 7.16K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.